Retrophin - An Upstart With Huge Potential January 17, 2013 | about: RTRX.OB Disclosure: I am long RTRX.OB, ARNA. (More...)
Retrophin (RTRX.OB) is a thinly covered pharmaceutical company that carries, in my opinion, tremendous upside potential. The company has 4 drugs in the pipeline with one, RE-021, being in phase II trials. The differences between Retrophin and other pharma companies is not only in the types of drugs the company is developing, but in the business model and management style as well. What sets Retrophin apart?...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.